Social Determinants of Health: Impact on Addiction Prevention, Treatment and Recovery-View Presentation

Video Transcription

Video Summary

In her session, Dr. Nora Volkow, Director of the National Institute on Drug Abuse, discusses the severe overdose crisis in the United States, emphasizing the complexity of the issue beyond just the pharmaceutical industry's role. The crisis, worsened since the 1990s, is now largely driven by illicit fentanyl mixed with other drugs. Volkow highlights cultural and systemic factors that increase vulnerability, with a focus on the neglect of substance use disorder treatment within the healthcare system. Social determinants of health, such as poverty and trauma, significantly impact addiction risk. Genetic factors also play a role, though environmental factors are more decisive.<br /><br />Volkow underscores the importance of understanding the interplay between genetics and environment in addiction vulnerability, emphasizing brain development stages and environmental impacts from childhood. She cites studies showing how early interventions can alter children's neurodevelopment trajectories positively. Policies providing direct cash benefits significantly enhance children's cognitive outcomes and brain health, especially those from low-income families.<br /><br />Emphasizing social support, Volkow draws attention to community-based interventions offering resilience against drug misuse. She advocates for policy changes, including decriminalizing drug use and focusing on treatment. Addressing attendees’ queries, she stresses integrating empathy and societal support into approaches to substance use disorders, arguing kindness and stronger social networks can offer substantial preventive and recovery benefits.

Keywords

overdose crisis

illicit fentanyl

substance use disorder

healthcare system

social determinants

genetic factors

environmental factors

brain development

early interventions

community-based interventions

policy changes

decriminalizing drug use

social support